Differences Between China And Europe In Evaluation Criteria For Supporting Patent Applications Involving Sequences

[Abstract] Patent applications involving biology and medicine have broad application prospects in production practice, and patent applications involving sequences account for a considerable proportion of such patent applications. The aim of this paper was to analyze the differences between China and Europe in the evaluation criteria for supporting patent applications involving sequences through three cases, with a view to providing a reference for applicants in relevant fields.

[Key words] sequence; supporting; differences between China and Europe

1. Introduction

In recent years, considerable progress has been made in the field of biotechnology. It is clear that patent applications involving biology and medicine are important for protecting future progress. Patent applications involving sequences account for a considerable proportion of such patent applications. In the examination practice of such patent applications, in addition to the issues of novelty,